The second half of August is usually a desert for business news, but the FDA schedule is year-round. Several important drugs are up for approval decisions this month, which could provide some upside for three biotech stocks that have recently been suffering. Getting the most attention will likely be Repatha, Amgen’s (AMGN) cholesterol drug. It’s expected to be approved by Aug. 27. Repatha is a PCSK9 inhibitor similar to Praluent, the drug from
The end of an era is drawing near for tech behemoth Hewlett-Packard (HPQ) and the company is laying the groundwork for its upcoming incarnation as two separate companies — one focused on enterprise technology and the other on personal computers and printers. HP on Wednesday announced the makeup of its two boards of directors, both of which will include HP’s current CEO, Meg Whitman. After the split, Whitman will be CEO of HP Enterprise and serve
Yahoo (YHOO) saw its stock slide to a 13-month low Wednesday as the value of its stake in China e-commerce leader Alibaba Group (BABA) continues to shrink. Yahoo stock was down more than 5% in midday trading in the stock market today, near 34. Yahoo stock is down 34% from a more than 14-year high of 52.62, touched on Nov. 18. Alibaba stock was down 6% midday Wednesday, near 72.50, after the company posted revenue that missed expectations for its